{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:12:50Z","timestamp":1786119170502,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1097\/01.mcg.0000225650.62190.40","type":"journal-article","created":{"date-parts":[[2009,3,4]],"date-time":"2009-03-04T23:17:17Z","timestamp":1236208637000},"page":"112-113","source":"Crossref","is-referenced-by-count":1,"title":["Thyrotoxic Periodic Paralysis Induced by Pegylated Interferon Alpha Plus Ribavirin for Chronic Hepatitis C"],"prefix":"10.1097","volume":"42","author":[{"given":"Wei-Shun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Lun","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Hua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guei-Bin","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwan-Dun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210305","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/archinte.164.21.2371","article-title":"Incidence of thyroid dysfunction during interferon alfa-2b and ribavirin therapy in men with chronic hepatitis C: a prospective cohort study","volume":"164","author":"Bini","year":"2004","journal-title":"Arch Intern Med"},{"key":"R2-22-20210305","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1478-3231.2005.01089.x","article-title":"Long-term outcome of interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C","volume":"25","author":"Doi","year":"2005","journal-title":"Liver Int"},{"key":"R3-22-20210305","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0168-8278(99)80131-7","article-title":"HLA antigens in patients with interferon-alpha-induced autoimmune thyroid disorders in chronic hepatitis C","volume":"30","author":"Kakizaki","year":"1999","journal-title":"J Hepatol"},{"key":"R4-22-20210305","doi-asserted-by":"crossref","first-page":"3656","DOI":"10.1210\/jc.2004-0627","article-title":"Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects","volume":"89","author":"Carella","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-22-20210305","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0025-6196(11)62965-0","article-title":"Thyrotoxic periodic paralysis","volume":"80","author":"Lin","year":"2005","journal-title":"Mayo Clin Proc"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004836-200801000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:43:09Z","timestamp":1786038189000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004836-200801000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mcg.0000225650.62190.40","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}